QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
QQQ   269.09 (-0.45%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
Log in

NASDAQ:IDEXIdeanomics Stock Price, Forecast & News

$1.35
-0.43 (-24.16 %)
(As of 08/11/2020 12:17 PM ET)
Add
Compare
Today's Range
$1.32
Now: $1.35
$1.52
50-Day Range
$1.22
MA: $1.59
$3.29
52-Week Range
$0.28
Now: $1.35
$3.98
Volume370,453 shs
Average Volume12.64 million shs
Market Capitalization$226.08 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.96
Ideanomics, Inc. operates as a financial technology and asset digitization services company. The company operates in two segments, Legacy YOD and Wecast Service. It engages in the provision of business consulting services related to traditional financings, as well as in developing digital asset securitization services through artificial intelligence and blockchain enabled financial services platforms. In addition, the company engages in consumer electronics e-commerce and smart supply chain management operations, as well as in oil trading business. Further, it provides premium content and integrated value-added service solutions for the delivery of video on demand and paid video programing to digital cable providers, Internet protocol television providers, over-the-top streaming providers, mobile manufacturers, and operators, as well as direct customers. The company was formerly known as Seven Stars Cloud Group, Inc. Ideanomics, Inc. was founded in 2004 and is headquartered in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Cable & other pay television services
Sub-IndustryN/A
Current SymbolNASDAQ:IDEX
CUSIPN/A
CIKN/A
Phone212-206-1216

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$44.57 million
Book Value$0.40 per share

Profitability

Net Income$-97,680,000.00
Net Margins-726.61%

Miscellaneous

Employees50
Market Cap$226.08 million
Next Earnings Date11/12/2020 (Estimated)
OptionableOptionable
$1.35
-0.43 (-24.16 %)
(As of 08/11/2020 12:17 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDEX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ideanomics (NASDAQ:IDEX) Frequently Asked Questions

How has Ideanomics' stock price been impacted by COVID-19 (Coronavirus)?

Ideanomics' stock was trading at $0.34 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IDEX stock has increased by 289.7% and is now trading at $1.3250.
View which stocks have been most impacted by COVID-19
.

When is Ideanomics' next earnings date?

Ideanomics is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Ideanomics
.

Has Ideanomics been receiving favorable news coverage?

Media stories about IDEX stock have trended neutral this week, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ideanomics earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Ideanomics
.

Are investors shorting Ideanomics?

Ideanomics saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 4,360,000 shares, an increase of 23.5% from the January 31st total of 3,530,000 shares. Based on an average daily volume of 472,700 shares, the days-to-cover ratio is presently 9.2 days. Approximately 8.0% of the company's stock are short sold.
View Ideanomics' Short Interest
.

Who are some of Ideanomics' key competitors?

What other stocks do shareholders of Ideanomics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ideanomics investors own include Genius Brands International (GNUS), NIO (NIO), Heat Biologics (HTBX), KITOV PHARMA LT/S (KTOV), Ibio (IBIO), Workhorse Group (WKHS), T2 Biosystems (TTOO), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Aurora Cannabis (ACB).

Who are Ideanomics' key executives?

Ideanomics' management team includes the following people:
  • Dr. Zheng Wu, Exec. Chairman (Age 53)
  • Mr. Alfred P. Poor, Pres, CEO, COO & Director (Age 49)
  • Mr. Shane B. McMahon, Founder & Vice Chairman (Age 49)
  • Mr. Richard Frankel, Exec. Vice Chairman (Age 54)
  • Mr. Federico Tovar, Chief Financial Officer (Age 45)

What is Ideanomics' stock symbol?

Ideanomics trades on the NASDAQ under the ticker symbol "IDEX."

Who are Ideanomics' major shareholders?

Ideanomics' stock is owned by many different retail and institutional investors. Top institutional investors include SG Americas Securities LLC (0.03%) and UBS Group AG (0.01%).

Which institutional investors are selling Ideanomics stock?

IDEX stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG.

Which institutional investors are buying Ideanomics stock?

IDEX stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC.

How do I buy shares of Ideanomics?

Shares of IDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ideanomics' stock price today?

One share of IDEX stock can currently be purchased for approximately $1.33.

How big of a company is Ideanomics?

Ideanomics has a market capitalization of $221.90 million and generates $44.57 million in revenue each year. Ideanomics employs 50 workers across the globe.

What is Ideanomics' official website?

The official website for Ideanomics is www.ideanomics.com.

How can I contact Ideanomics?

Ideanomics' mailing address is 55 BROADWAY 19TH FLOOR, NEW YORK NY, 10006. The company can be reached via phone at 212-206-1216 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.